Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice
- 1 September 1990
- journal article
- conference paper
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 26 (6) , 461-463
- https://doi.org/10.1007/bf02994100
Abstract
A simple and quantitative angiogenesis assay was developed. Using this assay, the angiostatic effect of cortisone acetate (CA) on three murine tumors was studied. Tumor cells were inoculated i.d. into the syngeneic or heterogeneic hosts (day 0) and the degree of angiogenesis was quantitated on day 3 by measuring the tumor vascular volumes using an Evan’s blue perfusion technique. CA treatment (250 mg/kg for 3 days) significantly suppressed tumor angiogenesis; however, the degree of angiostatic effect was influenced by the tumor types and by the mouse strain used. MBT-2 bladder cancer angiogenesis was suppressed by 77%–80% of controls in C3H/HeN and C57Bl/6 mice, whereas MBT-2 angiogenesis in BALB/c mice was significantly less suppressed by CA (65% inhibition) as compared with values obtained for C3H mice. B16 melanoma or Line-1 lung-cell carcinoma-induced angiogenesis was suppressed by 57%–66% in their syngeneic or heterogeneic hosts. The combined administration of CA and heparin (Sigma; 1,000 units/ml in drinking water) did not influence the outcomes. The data suggest that host factor(s) and tumor factor(s) influenced the expression of CA angiostatic activity. This colorimetric assay enabled a quantitative estimation of the degree of angiogenesis in mammalian animals.This publication has 13 references indexed in Scilit:
- Reduction of Tumor Blood Flow by Flavone Acetic Acid: A Possible Component of TherapyJNCI Journal of the National Cancer Institute, 1989
- Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor geneCell, 1989
- Investigation of Tumor Angiogenesis in an Id Mouse Model: Role of Host-Tumor InteractionsJNCI Journal of the National Cancer Institute, 1988
- INVIVO ENHANCEMENT OF ANTITUMOR IMMUNITY BY INTERLEUKIN 2-RICH LYMPHOKINES1986
- Treatment with cortisone plus heparin or hexuronyl hexoaminoglycan sulfates of murine tumors and their lung depositsClinical & Experimental Metastasis, 1985
- Effects of cortisone with and without heparin on angiogenesis induced by prostaglandin e1 and by s180 cells, and on growth of murine transplantable tumoursInternational Journal of Cancer, 1985
- Combination Heparin Plus Cortisone Treatment of Two Transplanted Tumors in C3H/He MiceJNCI Journal of the National Cancer Institute, 1985
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971
- A Simple Method for the Quantitative Extraction of Dye Extravasated into the SkinJournal of Pharmacy and Pharmacology, 1971